In a significant move to clarify the federal stance on the booming hemp industry, President Trump has urged Congress to refine the legal landscape for cannabis derivatives. The administration’s position represents a strategic “middle path”: protecting the legality and availability of full-spectrum CBD products while simultaneously calling for a crackdown on synthetic or high-potency hemp-derived intoxicants that regulators argue pose a significant risk to public health.
The White House’s directive aims to resolve the regulatory “gray area” created by the 2018 Farm Bill, which unintentionally opened the door for products like Delta-8 THC to be sold in convenience stores and gas stations with little oversight. Under the proposed framework, the federal government would maintain a “green light” for non-intoxicating CBD, recognizing its established market and therapeutic use for millions of Americans. However, it would grant federal agencies more aggressive authority to restrict products that mimic the intoxicating effects of traditional marijuana but bypass current safety and age-verification standards.
This policy shift reflects a growing concern among both conservative lawmakers and public health officials regarding the lack of standardized testing and packaging for “loophole” hemp products. By drawing a hard line between therapeutic CBD and unregulated intoxicants, the administration seeks to protect consumers—specifically children—from accidental ingestion of potent synthetics, while ensuring that the legitimate hemp-supplement industry is not dismantled by broad, overreaching bans.
For the cannabis industry, this move signals a more nuanced federal approach than the blanket prohibition of the past. By focusing on “health risks” rather than the plant itself, the administration is pivoting toward a CPG-style regulatory model centered on product safety and consumer transparency. As Congress prepares to debate the next Farm Bill, the President’s push for a bifurcated hemp market will likely serve as the primary blueprint for the future of hemp regulation in America.
Dabbin-Dad Newsroom
